image
Healthcare - Biotechnology - NASDAQ - US
$ 18.09
-0.768 %
$ 95.5 M
Market Cap
-9.62
P/E
CASH FLOW STATEMENT
-7.86 M OPERATING CASH FLOW
-8.71%
4.93 M INVESTING CASH FLOW
200.19%
2.03 M FINANCING CASH FLOW
6066.85%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Monopar Therapeutics Inc.
image
Net Income -8.4 M
Depreciation & Amortization 8.83 M
Capital Expenditures 0
Stock-Based Compensation 1.9 M
Change in Working Capital -1.35 M
Others -20.4 K
Free Cash Flow -7.86 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
OPERATING CASH FLOW
Net Income (8.4) (10.5) (9.1) (6.3) (4.2) (3.2) (16.6) (1.2) (0.7)
Depreciation & Amortization 0 0 0 0 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0 0 0 0 0
Stock Based Compensation 1.9 1.6 1.5 1.3 1.0 0.5 0.3 0 0
Other Operating Activities 0 0.2 1.1 (0.1) 0.8 0.4 13.5 9.33 K 73.8 K
Change in Working Capital (1.4) 1.6 0.3 0.4 0.2 (0.2) 0.1 9.04 K 51 K
Cash From Operations (7.9) (7.2) (7.3) (4.7) (3.0) (2.9) (2.6) (1.2) (0.6)
INVESTING CASH FLOW
Capital Expenditures 0 0 0 0 0 0 0 0 0
Other Items 4.9 (4.9) 0 0 0 0 0 0 0
Cash From Investing Activities 4.9 (4.9) 0 0 0 0 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0.1 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 47 K 76.5 K 45.8 K (0.1) (0.9) (0.2) 4.8 1.3 3.4
Cash From Financing Activities 2.0 32.9 K 10.9 8.2 9.3 (0.2) 9.5 1.3 3.4
CHANGE IN CASH
Net Change In Cash (0.9) (12.1) 3.6 3.5 6.3 (2.9) 6.9 67.9 K 2.8
FREE CASH FLOW
Free Cash Flow (7.9) (7.2) (7.3) (4.7) (3.0) (2.9) (2.6) (1.2) (0.6)